BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19731817)

  • 21. [Antidepressant treatment associated hyponatremia -- case report].
    Bognár Z; Vonyik G; Gazdag G
    Neuropsychopharmacol Hung; 2013 Sep; 15(3):177-80. PubMed ID: 24108183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of antidepressants on sleep].
    Aszalós Z
    Orv Hetil; 2006 Apr; 147(17):773-83. PubMed ID: 16780185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
    Nutt DJ
    Depress Anxiety; 1998; 7 Suppl 1():7-10. PubMed ID: 9597345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial.
    Prospero-Garcia KA; Torres-Ruiz A; Ramirez-Bermudez J; Velazquez-Moctezuma J; Arana-Lechuga Y; Teran-Perez G
    J Clin Psychiatry; 2006 Nov; 67(11):1820. PubMed ID: 17196069
    [No Abstract]   [Full Text] [Related]  

  • 26. Mirtazapine--another new class of antidepressant.
    Drug Ther Bull; 1999 Jan; 37(1):1-3. PubMed ID: 10562767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of mirtazapine on salivary cortisol in depressed patients.
    Laakmann G; Hennig J; Baghai T; Schüle C
    Neuropsychobiology; 2003; 47(1):31-6. PubMed ID: 12606843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mirtazapine--an antidepressant].
    Landowski J
    Psychiatr Pol; 2002; 36(6 Suppl):125-30. PubMed ID: 12647431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
    Kim SW; Shin IS; Kim JM; Kim YC; Kim KS; Kim KM; Yang SJ; Yoon JS
    Psychiatry Clin Neurosci; 2008 Feb; 62(1):75-83. PubMed ID: 18289144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serotonin neurotrasmission and treatment options for depression].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):174-177. PubMed ID: 29265105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant-associated mania: soon after switch from fluoxetine to mirtazapine in an elderly woman with mixed depressive features.
    Liu CC; Liang KY; Liao SC
    J Psychopharmacol; 2009 Mar; 23(2):220-2. PubMed ID: 18515466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute psychosis associated with dissociated sleep-wakefulness state after mirtazapine treatment.
    Felthous AR; Wenger PJ; Hoevet R
    Pharmacotherapy; 2010 Apr; 30(4):145e-50e. PubMed ID: 20334466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anxiolytic-like effect of mirtazapine mediates its effect in the median raphe nucleus.
    An Y; Inoue T; Kitaichi Y; Izumi T; Nakagawa S; Song N; Chen C; Li X; Koyama T; Kusumi I
    Eur J Pharmacol; 2013 Nov; 720(1-3):192-7. PubMed ID: 24436979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism.
    Nash JR; Wilson SJ; Potokar JP; Nutt DJ
    Neurology; 2003 Oct; 61(8):1161; author reply 1161. PubMed ID: 14581700
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical pharmacology of mirtazapine: revisited.
    Davis J; Barkin RL
    Am Fam Physician; 1999 Sep; 60(4):1101. PubMed ID: 10507741
    [No Abstract]   [Full Text] [Related]  

  • 39. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.
    Dolev Z
    Arch Womens Ment Health; 2011 Jun; 14(3):269-73. PubMed ID: 21311927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of mirtazapine on sleep in patients with major depressive disorder.
    Dolder CR; Nelson MH; Iler CA
    Ann Clin Psychiatry; 2012 Aug; 24(3):215-24. PubMed ID: 22860241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.